共 11 条
[1]
RISK OF HANDLING INJECTABLE ANTI-NEOPLASTIC AGENTS
[J].
AMERICAN JOURNAL OF HOSPITAL PHARMACY,
1982, 39 (11)
:1881-1887
[2]
JUSTIFYING AN IV ADDITIVE PROGRAM
[J].
DRUG INTELLIGENCE & CLINICAL PHARMACY,
1972, 6 (03)
:111-&
[3]
PERSONNEL TIME AND PREPARATION COSTS FOR COMPOUNDED VERSUS PREMIXED INTRAVENOUS ADMIXTURES IN 3 COMMUNITY HOSPITALS
[J].
AMERICAN JOURNAL OF HOSPITAL PHARMACY,
1988, 45 (03)
:605-608
[4]
ECONOMICS OF PROVIDING ANTINEOPLASTIC DRUGS IN A MANUFACTURER-MIXED BULK PACKAGE
[J].
AMERICAN JOURNAL OF HOSPITAL PHARMACY,
1988, 45 (01)
:109-115
[5]
EFFICIENCIES GAINED BY COMPUTERIZING A STERILE-PRODUCTS AREA
[J].
AMERICAN JOURNAL OF HOSPITAL PHARMACY,
1988, 45 (07)
:1554-1556
[6]
PERSONNEL COSTS AND PREPARATION TIME IN A CENTRALIZED INTRAVENOUS ADMIXTURE PROGRAM
[J].
AMERICAN JOURNAL OF HOSPITAL PHARMACY,
1986, 43 (05)
:1222-1225
[7]
WORK ANALYSIS OF AN ADMIXTURE SERVICE
[J].
AMERICAN JOURNAL OF HOSPITAL PHARMACY,
1983, 40 (12)
:2149-2153
[8]
PROJECTING STAFFING PATTERNS FROM TIME STUDY DATA IN CENTRALIZED INTRAVENOUS ADMIXTURE PROGRAMS
[J].
AMERICAN JOURNAL OF HOSPITAL PHARMACY,
1972, 29 (12)
:1013-1019
[9]
SHOUP LH, 1977, IMPERIAL BRAIN TRUST, P1
[10]
1976, AM J HOSP PHARM, V33, P231